Massachusetts Healthcare Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Healthcare Journal.

Press releases published on May 7, 2026

39 minutes ago

Exploring AI-Driven Approaches to Modernizing Probation and Parole in APPA’s Perspectives

Indeterminate EIN Presswire

34 minutes ago

Silo Pharma Files Provisional Patent for Ibogaine-Based Therapeutic Targeting Traumatic Brain Injury

Indeterminate GlobeNewswire

34 minutes ago

Scienture Secures $11.0 Million in Non-Dilutive Debt Financing to Accelerate Growth of Approved Product Portfolio and Advancement of R&D Pipeline

Indeterminate GlobeNewswire

38 minutes ago

Ardelyx Presents Analysis Supporting Long-Term Safety of XPHOZAH at NKF’s Spring Clinical Meetings

Indeterminate GlobeNewswire

39 minutes ago

Krystal Biotech to Present at BofA Securities 2026 Health Care Conference

Indeterminate GlobeNewswire

39 minutes ago

Daré Bioscience to Host First Quarter 2026 Financial Results and Company Update Conference Call and Webcast on May 14, 2026

Indeterminate GlobeNewswire

39 minutes ago

vTv Therapeutics to Participate in Upcoming May Investor Conferences

Indeterminate GlobeNewswire

39 minutes ago

MBX Biosciences Reports First Quarter 2026 Financial Results and Corporate Highlights

Indeterminate GlobeNewswire

39 minutes ago

MediWound to Report First Quarter 2026 Financial Results

Indeterminate GlobeNewswire

39 minutes ago

Stryker declares an $0.88 per share quarterly dividend

Indeterminate GlobeNewswire

39 minutes ago

ARS Pharmaceuticals Announces Conference Call and Webcast for its First Quarter 2026 Financial Results

Indeterminate GlobeNewswire

39 minutes ago

ArriVent Announces IND Clearance for Novel Tetravalent MUC16/NaPi2b Targeting ADC ARR-002 with Initial Focus in Ovarian and Endometrial Cancers

Indeterminate GlobeNewswire

39 minutes ago

Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire

39 minutes ago

Solid Biosciences Doses First Participant in Phase 3 IMPACT DUCHENNE Clinical Trial Evaluating SGT-003 in Duchenne Muscular Dystrophy

Indeterminate GlobeNewswire

39 minutes ago

Prime Medicine Reports First Quarter 2026 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire

39 minutes ago

ALX Oncology’s Evorpacept in Combination with Zanidatamab Generates Promising, Durable Response in Patients with Advanced HER2-Positive Breast Cancer and High CD47 Expression

Indeterminate GlobeNewswire

39 minutes ago

Filana Therapeutics Reports Q1 2026 Financial Results and Business Update

Indeterminate GlobeNewswire

39 minutes ago

Celcuity Schedules Release of First Quarter 2026 Financial Results and Webcast/Conference Call

Indeterminate GlobeNewswire

39 minutes ago

UroGen Pharma to Present at Upcoming Investor Conferences

Indeterminate GlobeNewswire

39 minutes ago

NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Clearance to Proceed with Clinical Trial of NRX-101 in Combination with Robotic-enabled Transcranial Magnetic Stimulation in Patients with Depression and Suicidality

Indeterminate GlobeNewswire